Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008758

10% owner bought 350,000 shares at $20.00 ($7,000,000)

  • 10% owner sold 226 shares at $20.00 ($4,520)
  • 10% owner acquired 64,319 shares (option exercise)
  • 10% owner acquired 3,414,343 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion +944,056 958,341 I: show line 1 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion +472,296 1,430,637 I: show line 2 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Option exercise +17,711 $0.07 $1,240 1,448,348 I: show line 3 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Sale −62 $20.00 $1,240 1,448,286 I: show line 4 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion +1,092,080 1,117,184 I: show line 5 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion +317,922 1,435,106 I: show line 6 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion +345,568 1,780,674 I: show line 7 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Option exercise +40,953 $0.07 $2,867 1,821,627 I: show line 8 in the form
Open-market purchases · 350,000 sh · avg $20.00 · $7,000,000
Open-market sales · 226 sh · avg $20.00 · $4,520

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion · Series A-1 Preferred Stock −944,056 0 I: show line 18 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion · Series B Preferred Stock −472,296 0 I: show line 19 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Option exercise · Warrant (Right to Buy) −17,711 0 I: show line 20 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion · Series B Preferred Stock −1,092,080 0 I: show line 21 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion · Series C-1 Preferred Stock −317,922 0 I: show line 22 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion · Series C-2 Preferred Stock −345,568 0 I: show line 23 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Option exercise · Warrant (Right to Buy) −40,953 0 I: show line 24 in the form
Vivo Capital VIII, LLC 10% owner 2021-02-09 Conversion · Series B Preferred Stock −150,802 0 I: show line 25 in the form
Loading xslF345X03/doc4.xml…